{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:27:16Z","timestamp":1794335236971,"version":"4.9.0"},"reference-count":138,"publisher":"Informa UK Limited","issue":"12","license":[{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Metabolism & Toxicology"],"published-print":{"date-parts":[[2023,12,2]]},"DOI":"10.1080\/17425255.2023.2287472","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T09:09:42Z","timestamp":1700644182000},"page":"911-923","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":85,"title":["Pharmacokinetics and pharmacodynamics of direct oral anticoagulants"],"prefix":"10.1080","volume":"19","author":[{"given":"B.","family":"Hindley","sequence":"first","affiliation":[{"name":"Pharmacy Department, Aintree University Hospital, Liverpool, UK"},{"name":"Clinical Pharmacy and Therapeutics Research Group, School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.Y.H.","family":"Lip","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, UK"},{"name":"Danish Center for Clinical Health Services Research, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.P.","family":"McCloskey","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy and Therapeutics Research Group, School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK"},{"name":"Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6763-1489","authenticated-orcid":false,"given":"P.E.","family":"Penson","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy and Therapeutics Research Group, School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK"},{"name":"Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,11,24]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.017559"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.29074\/ascls.30.1.2"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-019-00775-z"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2015.11.025"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-014-0261-1"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-015-0342-7"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-013-0100-7"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270007302952"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200847010-00005"},{"key":"e_1_3_4_11_1","unstructured":"Electronic Medicines Compendium. Pradaxa 150mg hard capsules [Internet]. 2022 [cited 2023 Jan 27]. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/4703\/smpc."},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.110.203604"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2020.10.011"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2020.09.002"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/19418744231161390"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcr\/ytaa178"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy136"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1055\/a-1753-2748"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-1750327"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17470"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-9560-11-11"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1055\/a-1981-1763"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1055\/a-1450-8178"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-013-0055-y"},{"key":"e_1_3_4_25_1","unstructured":"Daiichi Sankyo Europe GmbH. Lixiana summary of product characteristics [Internet]. 2020 [cited 2022 Dec 23]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/lixiana-epar-product-information_en.pdf."},{"key":"e_1_3_4_26_1","unstructured":"Electronic Medicines Compendium. Lixiana 60mg film-coated tablets [Internet]. 2022 [cited 2022 Dec 23]. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/6905\/smpc#gref."},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-016-0485-1"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/emermed-2012-201976"},{"key":"e_1_3_4_29_1","unstructured":"Boehringer Ingelheim Pharmaceuticals Inc. Pradaxa prescribing infomation [Internet]. 2011 [cited 2023 Jan 27]. Ava: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/022512s007lbl.pdf."},{"key":"e_1_3_4_30_1","unstructured":"Boehringer Ingelheim International GmbH. Pradaxa summary of product characteristics [Internet]. 2018 [cited 2023 Jan 27]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/pradaxa-epar-product-information_en.pdf."},{"key":"e_1_3_4_31_1","unstructured":"Electronic Medicines Compendium. Ondexxya 200 mg powder for solution for infusion [Internet]. 2022 [cited 2022 Dec 12]. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/10933\/smpc."},{"key":"e_1_3_4_32_1","unstructured":"Electronic Medicines Compendium. Praxbind 2.5 g\/50 mL solution for injection\/infusion [Internet]. 2022 [cited 2023 Feb 3]. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/5073."},{"key":"e_1_3_4_33_1","unstructured":"Alexion Europe SAS. Ondexxya summary of product characterisitcs [Internet]. 2021 [cited 2023 Feb 10]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/ondexxya-epar-product-information_en.pdf."},{"key":"e_1_3_4_34_1","unstructured":"Alexion Pharmaceuticals Inc. Andexxa prescribing information [Internet]. 2022 [cited 2023 Feb 10]. Available from: https:\/\/www.fda.gov\/media\/113279\/download."},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1740180"},{"key":"e_1_3_4_36_1","unstructured":"National Institute of Health. Trial of andexanet alfa in ICH patients receiving an oral FXa inhibitor [Internet]. 2023 [cited 2023 Feb 10]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03661528."},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13049-019-0625-3"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.21406"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1097"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-015-0157-9"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2016.05.004"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2012.04369.x"},{"key":"e_1_3_4_43_1","unstructured":"Electronic Medicines Compendium. Eliquis 5 mg film-coated tablets [Internet]. 2022 [cited 2022 Dec 12]. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/2878\/smpc."},{"key":"e_1_3_4_44_1","unstructured":"Bristol-Myers Squibb\/Pfizer EEIG. Eliquis summary of product characteristics [Internet]. 2021 [cited 2022 Dec 23]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/eliquis-epar-product-information_en.pdf."},{"key":"e_1_3_4_45_1","unstructured":"Bristol-Myers Squibb Company PI. Eliquis (apixaban) prescribing information. [Internet]. 2021 [cited 2022 Dec 12]. Available from: https:\/\/packageinserts.bms.com\/pi\/pi_eliquis.pdf."},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12106"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2015.05.497"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12114"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V130.Suppl_1.1105.1105"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10020200"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-021-01716-8"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2651"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2021.10.009"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-022-00524-x"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13318-011-0037-x"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-014-0228-0"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12347"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.109.029694"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.112.050260"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.647"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12650"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2022.10.031"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2023.02.012"},{"key":"e_1_3_4_64_1","unstructured":"U.S. Food and Drug Administration. FDA\u2019s Examples of Drugs that Interact with CYP Enzymes and Transporter Systems. 2023."},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.108.023143"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2019.1604686"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.633"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12184"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.035418"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.119.044059"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-021-07144-8"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1740254"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2021.08.022"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2022.10.014"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.062752"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.540"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-014-1736-4"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.53"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.1156"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270010370974"},{"key":"e_1_3_4_81_1","unstructured":"Daiichi Sankyo Co. L. Edoxaban (Savaysa) prescribing information [Internet]. 2015 [cited 2022 Dec 23]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/206316lbl.pdf."},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-017-0554-0"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12178"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-014-0229-7"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15358"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1716540"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-016-0378-3"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.112.046888"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.113.054866"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.550"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.541"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.329"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu181"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-022-00403-5"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.118.021387"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-018-0693-6"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1306638"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.022361"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-016-1465-x"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.5484"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.5414\/CP201812"},{"key":"e_1_3_4_102_1","unstructured":"Janssen Pharmaceuticals. XARELTO (rivaroxaban) [Internet]. 2014 [cited 2023 Jan 13]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/022406s015lbl.pdf."},{"key":"e_1_3_4_103_1","unstructured":"Electronic Medicines Compendium. Xarelto 15mg & 20mg film-coated tablets treatment initiation pack [Internet]. 2022 [cited 2023 Jan 13]. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/8419\/smpc#gref."},{"key":"e_1_3_4_104_1","unstructured":"Electronic Medicines Compendium. Xarelto 10 mg film-coated tablets [Internet]. 2022 [cited 2023 Jan 13]. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/6402\/smpc."},{"key":"e_1_3_4_105_1","unstructured":"Bayer AG Xarelto summary of product characteristics. 2018 [cited 2023 Jan 13]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/xarelto-epar-product-information_en.pdf."},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.123"},{"key":"e_1_3_4_107_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-020-00434-w"},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270006296058"},{"key":"e_1_3_4_109_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.5"},{"key":"e_1_3_4_110_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12075"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12111040"},{"key":"e_1_3_4_112_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12054"},{"key":"e_1_3_4_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.03.023"},{"key":"e_1_3_4_114_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2010.03753.x"},{"key":"e_1_3_4_115_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1838"},{"key":"e_1_3_4_116_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-019-00776-y"},{"key":"e_1_3_4_117_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17004"},{"key":"e_1_3_4_118_1","doi-asserted-by":"publisher","DOI":"10.1177\/1076029609343004"},{"key":"e_1_3_4_119_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270005274550"},{"key":"e_1_3_4_120_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2007.02899.x"},{"key":"e_1_3_4_121_1","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12146"},{"key":"e_1_3_4_122_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac544.629"},{"key":"e_1_3_4_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2021.11.007"},{"key":"e_1_3_4_124_1","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euab065"},{"key":"e_1_3_4_125_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.107.019083"},{"key":"e_1_3_4_126_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.110.033696"},{"key":"e_1_3_4_127_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270008324179"},{"key":"e_1_3_4_128_1","doi-asserted-by":"publisher","DOI":"10.2165\/11318170-000000000-00000"},{"key":"e_1_3_4_129_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40292-020-00373-2"},{"key":"e_1_3_4_130_1","unstructured":"Medicines and Healthcare Products Regulatory Agency. Prescribing medicines in renal impairment: using the appropriate estimate of renal function to avoid the risk of adverse drug reactions [Internet]. 2019 [cited 2022 Dec 12]. Available from: https:\/\/www.gov.uk\/drug-safety-update\/prescribing-medicines-in-renal-impairment-using-the-appropriate-estimate-of-renal-function-to-avoid-the-risk-of-adverse-drug-reactions."},{"key":"e_1_3_4_131_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003343"},{"key":"e_1_3_4_132_1","unstructured":"NHS North West Coast Strategic Networks. Consensus statement on how to calculate the creatinine clearance (CrCl) which is necessary when assessing the dose of direct-acting oral anticoagulants (DOACs) [Internet]. 2018 [cited 2022 Dec 12]. Available from: https:\/\/www.england.nhs.uk\/north\/wp-content\/uploads\/sites\/5\/2019\/01\/consensus-statement-on-CrCl-calculation-for-DOACs-final.pdf."},{"key":"e_1_3_4_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2017.06.004"},{"key":"e_1_3_4_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2017.04.015"},{"key":"e_1_3_4_135_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.14288"},{"key":"e_1_3_4_136_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13323"},{"key":"e_1_3_4_137_1","doi-asserted-by":"publisher","DOI":"10.1177\/10600280221077158"},{"key":"e_1_3_4_138_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-023-02774-1"},{"key":"e_1_3_4_139_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2021.02.002"}],"container-title":["Expert Opinion on Drug Metabolism & Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425255.2023.2287472","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T18:08:17Z","timestamp":1727201297000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17425255.2023.2287472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,24]]},"references-count":138,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12,2]]}},"alternative-id":["10.1080\/17425255.2023.2287472"],"URL":"https:\/\/doi.org\/10.1080\/17425255.2023.2287472","relation":{},"ISSN":["1742-5255","1744-7607"],"issn-type":[{"value":"1742-5255","type":"print"},{"value":"1744-7607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-06-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}